Table 1.
Clinicopathologic Characteristics of 160 Patients with Clinically Localized Prostate Cancer Treated by Radical Prostatectomy.
| Age, y | ||
| ≤ 60 | 86 | (53.8%) |
| > 60 | 74 | (46.2%) |
| GS | ||
| < 7 | 41 | (25.6%) |
| = 7 | 109 | (68.1%) |
| > 7 | 10 | (6.3%) |
| Tumor size, cm | ||
| < 1 | 25 | (15.6%) |
| ≥ 1 | 135 | (84.4%) |
| AJCC T stage | ||
| pT2a | 19 | (11.9%) |
| pT2b | 103 | (64.4%) |
| pT3a | 31 | (19.4%) |
| pT3b | 6 | (3.8%) |
| pT4 | 1 | (0.6%) |
| Surgical margin | ||
| Negative | 114 | (71.2%) |
| Positive | 46 | (28.8%) |
| Preoperative PSA, ng/ml | ||
| < 4 | 22 | (13.8%) |
| 4-7 | 68 | (42.5%) |
| > 7 | 70 | (43.8%) |
| PSA recurrence | ||
| No | 109 | (68.1%) |
| Yes | 51 | (31.9%) |